# Three Times Daily Dosing of UT-15C

> **NCT01746485** · PHASE1 · COMPLETED · sponsor: **United Therapeutics** · enrollment: 19 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** UT-15C

## Key facts

- **NCT ID:** NCT01746485
- **Lead sponsor:** United Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2012-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01746485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01746485, "Three Times Daily Dosing of UT-15C". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01746485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*